Sign in

CIK 0001479419

  • Non-accelerated filer
  • Smaller reporting company

KALA BIO, Inc.

Sign in to watch
Ticker
KALA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
270604595
Phone
+1 781-996-5252
Business address
1167 MASSACHUSETTS AVENUE, ARLINGTON, MA, 02476
Former names
KALA BIO, Inc., Kala Pharmaceuticals, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-06-15 PERRY GREGORY D Director Grant or award +2,450 13,344
2025-06-15 PERRY GREGORY D Director Grant or award · Stock Option (right to buy) +5,450 5,450
2024-06-11 PERRY GREGORY D Director Grant or award +1,400 10,894
2024-06-11 PERRY GREGORY D Director Grant or award · Stock Option (right to buy) +3,150 3,150
2023-06-22 PERRY GREGORY D Director Grant or award +5,856 8,394
2023-06-22 PERRY GREGORY D Director Grant or award +1,100 9,494
2023-06-22 PERRY GREGORY D Director Grant or award · Stock Option (right to buy) +7,808 7,808
2023-06-22 PERRY GREGORY D Director Grant or award · Stock Option (right to buy) +2,500 2,500
2023-05-31 PERRY GREGORY D Director Grant or award +1,738 2,538
2023-05-31 PERRY GREGORY D Director Returned to the company · Stock Option (right to buy) −518 0
2023-05-31 PERRY GREGORY D Director Returned to the company · Stock Option (right to buy) −420 0
2023-05-31 PERRY GREGORY D Director Returned to the company · Stock Option (right to buy) −800 0

Page 1 of 1 · 12 trades